Q&A: FDA Panel Member Tells Healthline Why He Resigned Over Alzheimer’s Drug Approval
Similar Posts
MobileSmith Health Appoints Chris Caramanico CEO
Veteran industry executive to guide company’s continued evolution in bridging gap between mobile health technology and patient adherence…
CarePayment Now Available for MyChart Integration through Epic’s App Orchard
CAREPAYMENT PATIENT FINANCING NOW AVAILABLE IN EPIC APP ORCHARD MARKETPLACE WITH NEW MYCHART INTEGRATION CarePayment, a leading patient financing…
VyncaCare Appoints Dr. Angela Poppe Ries as Chief Medical Officer
Poppe Ries to Drive Strategy for VyncaCare’s Evolving Supportive Services Model VyncaCare, a serious illness management platform that couples…
David Abramson Named President of Israel Cancer Research Fund
Chicago Businessman to Head Largest Non-Profit Dedicated to Funding Cancer Research in Israel David Abramson, a resident of Northbrook, Illinois,…
athenahealth Adds Szkutak to Board of Directors
Former Amazon.com CFO to Lend Experience and Leadership as athenahealth Grows, Scales, and Approaches New Business Opportunities athenahealth, Inc. (NASDAQ:ATHN),…
